Notable Announces Leadership Team Expansion
09 avr. 2020 14h03 HE
|
Notable Labs
SAN FRANCISCO, April 09, 2020 (GLOBE NEWSWIRE) -- Notable, a technology leader redefining cancer treatment through rapid drug development via a clinically validated platform, announced today its...
SEngine Precision Medicine Raises $5.1 Million Series A to Advance Personalized Oncology Drug Discovery Platform
02 oct. 2019 09h00 HE
|
SEngine Precision Medicine
SEATTLE, Wash., Oct. 02, 2019 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, an oncology pioneer accelerating cancer drug discovery through its CLIA certified, proprietary diagnostic platform...
Notable Announces $40M Series B Round to Fuel Development of Its Drug Discovery Platform for Personalized Oncology
16 juil. 2019 07h00 HE
|
Notable Labs
SAN FRANCISCO, July 16, 2019 (GLOBE NEWSWIRE) -- Notable, which is redefining cancer treatment with a clinically validated platform that rapidly advances cancer drug development at a fraction of the...
Champions Oncology Receives Accreditation From The Joint Commission
02 janv. 2014 16h00 HE
|
Champions Oncology
HACKENSACK, N.J., Jan. 2, 2014 (GLOBE NEWSWIRE) -- Champions Oncology (OTC:CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and...
Champions Oncology Reports Results for the Quarter Ended October 31, 2013
12 déc. 2013 16h00 HE
|
Champions Oncology
HACKENSACK, N.J., Dec. 12, 2013 (GLOBE NEWSWIRE) -- Champions Oncology, Inc. (OTC:CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use...
Enrollment Commenced in Barnabas Health and Champions Oncology Breast Cancer Research Trial
10 déc. 2013 16h00 HE
|
Champions Oncology
HACKENSACK, N.J., Dec. 10, 2013 (GLOBE NEWSWIRE) -- Champions Oncology (OTC:CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and...
Champions Oncology to Present at the Aegis Capital Corp. 2013 Healthcare Conference
25 sept. 2013 07h00 HE
|
Champions Oncology
HACKENSACK, N.J., Sept. 25, 2013 (GLOBE NEWSWIRE) -- Champions Oncology (OTC:CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development...
Champions Oncology Reports Results for the Quarter Ended July 31, 2013
13 sept. 2013 06h30 HE
|
Champions Oncology
HACKENSACK, N.J., Sept. 13, 2013 (GLOBE NEWSWIRE) -- Champions Oncology, Inc. (OTC:CSBR), engaged in the development of advanced technology solutions and services to personalize the development and...
Champions Oncology and Teva Sign a Discovery and Drug Development Partnership
12 sept. 2013 16h07 HE
|
Champions Oncology
HACKENSACK, N.J., Sept. 12, 2013 (GLOBE NEWSWIRE) -- Champions Oncology Inc. (OTC:CSBR) ("Champions"), a company engaged in the development of advanced technology solutions and services to personalize...